308 related articles for article (PubMed ID: 23650550)
1. In vivo "MRI phenotyping" reveals changes in extracellular matrix transport and vascularization that mediate VEGF-driven increase in breast cancer metastasis.
Pathak AP; McNutt S; Shah T; Wildes F; Raman V; Bhujwalla ZM
PLoS One; 2013; 8(5):e63146. PubMed ID: 23650550
[TBL] [Abstract][Full Text] [Related]
2. Effects of MDM2 inhibitors on vascular endothelial growth factor-mediated tumor angiogenesis in human breast cancer.
Xiong J; Yang Q; Li J; Zhou S
Angiogenesis; 2014 Jan; 17(1):37-50. PubMed ID: 23907365
[TBL] [Abstract][Full Text] [Related]
3. VEGF-C induced lymphangiogenesis is associated with lymph node metastasis in orthotopic MCF-7 tumors.
Mattila MM; Ruohola JK; Karpanen T; Jackson DG; Alitalo K; Härkönen PL
Int J Cancer; 2002 Apr; 98(6):946-51. PubMed ID: 11948478
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of tumor growth and vascular density by transfection of vascular endothelial cell growth factor into MCF-7 human breast carcinoma cells.
Zhang HT; Craft P; Scott PA; Ziche M; Weich HA; Harris AL; Bicknell R
J Natl Cancer Inst; 1995 Feb; 87(3):213-9. PubMed ID: 7535859
[TBL] [Abstract][Full Text] [Related]
5. Stemness marker ALDH1A1 promotes tumor angiogenesis via retinoic acid/HIF-1α/VEGF signalling in MCF-7 breast cancer cells.
Ciccone V; Terzuoli E; Donnini S; Giachetti A; Morbidelli L; Ziche M
J Exp Clin Cancer Res; 2018 Dec; 37(1):311. PubMed ID: 30541574
[TBL] [Abstract][Full Text] [Related]
6. P2Y2 receptor activation by nucleotides released from highly metastatic breast cancer cells increases tumor growth and invasion via crosstalk with endothelial cells.
Jin H; Eun SY; Lee JS; Park SW; Lee JH; Chang KC; Kim HJ
Breast Cancer Res; 2014 Aug; 16(5):R77. PubMed ID: 25156554
[TBL] [Abstract][Full Text] [Related]
7. Twist overexpression induces in vivo angiogenesis and correlates with chromosomal instability in breast cancer.
Mironchik Y; Winnard PT; Vesuna F; Kato Y; Wildes F; Pathak AP; Kominsky S; Artemov D; Bhujwalla Z; Van Diest P; Burger H; Glackin C; Raman V
Cancer Res; 2005 Dec; 65(23):10801-9. PubMed ID: 16322226
[TBL] [Abstract][Full Text] [Related]
8. The Angiogenic Secretome in VEGF overexpressing Breast Cancer Xenografts.
Dore-Savard L; Lee E; Kakkad S; Popel AS; Bhujwalla ZM
Sci Rep; 2016 Dec; 6():39460. PubMed ID: 27995973
[TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor is a target gene for estrogen receptor and contributes to breast cancer progression.
Applanat MP; Buteau-Lozano H; Herve MA; Corpet A
Adv Exp Med Biol; 2008; 617():437-44. PubMed ID: 18497067
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of the chimeric plasmin-resistant VEGF165/VEGF183 (132-158) protein in murine breast cancer induces distinct vascular patterning adjacent to tumors and retarded tumor growth.
Zhang HY; Fan BL; Wu XS; Mu LM; Wang WF; Zhu WL
Mol Med Rep; 2015 Feb; 11(2):1483-9. PubMed ID: 25373557
[TBL] [Abstract][Full Text] [Related]
11. Cyclooxygenase-2 directly induces MCF-7 breast tumor cells to develop into exponentially growing, highly angiogenic and regionally invasive human ductal carcinoma xenografts.
Robertson FM; Mallery SR; Bergdall-Costell VK; Cheng M; Pei P; Prosperi JR; Ferrari M
Anticancer Res; 2007; 27(2):719-27. PubMed ID: 17465194
[TBL] [Abstract][Full Text] [Related]
12. Lymph node metastasis in breast cancer xenografts is associated with increased regions of extravascular drain, lymphatic vessel area, and invasive phenotype.
Pathak AP; Artemov D; Neeman M; Bhujwalla ZM
Cancer Res; 2006 May; 66(10):5151-8. PubMed ID: 16707438
[TBL] [Abstract][Full Text] [Related]
13. Vascular differences detected by MRI for metastatic versus nonmetastatic breast and prostate cancer xenografts.
Bhujwalla ZM; Artemov D; Natarajan K; Ackerstaff E; Solaiyappan M
Neoplasia; 2001; 3(2):143-53. PubMed ID: 11420750
[TBL] [Abstract][Full Text] [Related]
14. ErbB2 increases vascular endothelial growth factor protein synthesis via activation of mammalian target of rapamycin/p70S6K leading to increased angiogenesis and spontaneous metastasis of human breast cancer cells.
Klos KS; Wyszomierski SL; Sun M; Tan M; Zhou X; Li P; Yang W; Yin G; Hittelman WN; Yu D
Cancer Res; 2006 Feb; 66(4):2028-37. PubMed ID: 16489002
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-140-5p inhibits invasion and angiogenesis through targeting VEGF-A in breast cancer.
Lu Y; Qin T; Li J; Wang L; Zhang Q; Jiang Z; Mao J
Cancer Gene Ther; 2017 Sep; 24(9):386-392. PubMed ID: 28752859
[TBL] [Abstract][Full Text] [Related]
16. VEGF/NRP-1axis promotes progression of breast cancer via enhancement of epithelial-mesenchymal transition and activation of NF-κB and β-catenin.
Luo M; Hou L; Li J; Shao S; Huang S; Meng D; Liu L; Feng L; Xia P; Qin T; Zhao X
Cancer Lett; 2016 Apr; 373(1):1-11. PubMed ID: 26805761
[TBL] [Abstract][Full Text] [Related]
17. Permeability to macromolecular contrast media quantified by dynamic MRI correlates with tumor tissue assays of vascular endothelial growth factor (VEGF).
Cyran CC; Sennino B; Fu Y; Rogut V; Shames DM; Chaopathomkul B; Wendland MF; McDonald DM; Brasch RC; Raatschen HJ
Eur J Radiol; 2012 May; 81(5):891-6. PubMed ID: 21889860
[TBL] [Abstract][Full Text] [Related]
18. Platelet releasate promotes breast cancer growth and angiogenesis via VEGF-integrin cooperative signalling.
Jiang L; Luan Y; Miao X; Sun C; Li K; Huang Z; Xu D; Zhang M; Kong F; Li N
Br J Cancer; 2017 Aug; 117(5):695-703. PubMed ID: 28697175
[TBL] [Abstract][Full Text] [Related]
19. Mesothelin promotes invasion and metastasis in breast cancer cells.
Wang Y; Wang L; Li D; Wang HB; Chen QF
J Int Med Res; 2012; 40(6):2109-16. PubMed ID: 23321167
[TBL] [Abstract][Full Text] [Related]
20. Over expressing miR-19b-1 suppress breast cancer growth by inhibiting tumor microenvironment induced angiogenesis.
Yin R; Guo L; Gu J; Li C; Zhang W
Int J Biochem Cell Biol; 2018 Apr; 97():43-51. PubMed ID: 29425833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]